If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

DNLI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,518,964.35

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

^$23.26

▼ -0.07 (-0.30%)

As of 03/21/2023 05:00 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Denali Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2023	Carole Ho	Insider	Sell	2,548	$30.10	$76,694.80	184,285
2/13/2023	Ryan J Watts	CEO	Sell	33,815	$30.08	$1,017,155.20	2,239,913
2/13/2023	Steve E Krognes	Director	Sell	2,119	$30.10	$63,781.90	143,002
2/10/2023	Carole Ho	Insider	Sell	818	$29.80	$24,376.40	179,365
2/10/2023	Ryan J Watts	CEO	Sell	25,000	$29.10	$727,500.00	2,229,031
2/8/2023	Carole Ho	Insider	Sell	1,521	$30.88	$46,968.48	180,183
2/8/2023	Steve E Krognes	Director	Sell	1,377	$30.88	$42,521.76	145,121
1/17/2023	Alexander O Schuth	Insider	Sell	10,000	$29.53	$295,300.00	497,173
1/9/2023	Carole Ho	Insider	Sell	1,459	$28.48	$41,552.32	177,454
1/6/2023	Carole Ho	Insider	Sell	1,451	$28.67	$41,600.17	178,913
1/5/2023	Steve E Krognes	Director	Sell	2,970	$28.44	$84,466.80	146,498
1/4/2023	Carole Ho	Insider	Sell	2,913	$28.69	$83,573.97	175,500
1/4/2023	Ryan J Watts	CEO	Sell	5,029	$28.73	$144,483.17	2,213,464
11/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.48	$609,600.00	1,870,356
11/1/2022	Marc Tessier-Lavigne	Director	Sell	8,748	$30.20	$264,189.60	1,901,608
9/28/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.82	$616,400.00	1,910,356
8/23/2022	Carole Ho	Insider	Sell	2,424	$31.98	$77,519.52	170,663
8/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$31.61	$632,200.00	1,930,356
8/19/2022	Alexander O Schuth	Insider	Sell	2,576	$33.22	$85,574.72	467,471
8/19/2022	Ryan J Watts	CEO	Sell	2,404	$33.22	$79,860.88	2,202,993
8/19/2022	Steve E Krognes	Director	Sell	2,253	$33.22	$74,844.66	149,468
7/25/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$35.61	$712,200.00	1,950,356
3/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$33.83	$676,600.00
2/11/2022	Alexander O Schuth	COO	Sell	2,803	$34.68	$97,208.04
2/11/2022	Carole Ho	Insider	Sell	2,918	$34.71	$101,283.78
2/11/2022	Ryan J Watts	CEO	Sell	9,491	$34.72	$329,527.52
2/11/2022	Steve E Krognes	CFO	Sell	2,560	$34.69	$88,806.40
2/9/2022	Alexander O Schuth	COO	Sell	1,423	$37.10	$52,793.30
2/9/2022	Ryan J Watts	CEO	Sell	2,719	$37.55	$102,098.45
2/9/2022	Steve E Krognes	CFO	Sell	1,296	$37.09	$48,068.64
1/5/2022	Alexander O Schuth	COO	Sell	2,846	$44.77	$127,415.42
1/5/2022	Carole Ho	Insider	Sell	2,845	$44.78	$127,399.10
1/5/2022	Ryan J Watts	CEO	Sell	5,007	$44.78	$224,213.46
1/5/2022	Steve E Krognes	CFO	Sell	2,225	$44.75	$99,568.75
12/30/2021	Marc Tessier-Lavigne	Director	Sell	20,047	$45.36	$909,331.92
12/28/2021	Marc Tessier-Lavigne	Director	Sell	10,980	$44.37	$487,182.60
12/6/2021	Alexander O Schuth	COO	Sell	10,000	$42.27	$422,700.00
12/6/2021	Carole Ho	Insider	Sell	1,476	$42.52	$62,759.52
12/1/2021	Ryan J Watts	CEO	Sell	18,333	$44.92	$823,518.36
11/10/2021	Vicki L. Sato	Director	Sell	1,666	$52.81	$87,981.46
11/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.84	$528,400.00
10/4/2021	Alexander O Schuth	COO	Sell	10,000	$50.56	$505,600.00
9/15/2021	Vicki L. Sato	Director	Sell	1,666	$53.40	$88,964.40
9/7/2021	Alexander O Schuth	COO	Sell	10,000	$55.55	$555,500.00
9/1/2021	Ryan J. Watts	CEO	Sell	18,333	$54.66	$1,002,081.78
8/23/2021	Carole Ho	Insider	Sell	6,143	$48.91	$300,454.13
8/19/2021	Alexander O Schuth	COO	Sell	2,544	$49.60	$126,182.40
8/19/2021	Carole Ho	Insider	Sell	2,546	$49.58	$126,230.68
8/19/2021	Ryan J Watts	CEO	Sell	2,376	$49.57	$117,778.32
8/19/2021	Steve E. Krognes	CFO	Sell	2,285	$49.57	$113,267.45
8/18/2021	Vicki L. Sato	Director	Sell	1,666	$51.70	$86,132.20
8/4/2021	Alexander O Schuth	COO	Sell	10,000	$52.22	$522,200.00
8/2/2021	Ryan J Watts	CEO	Sell	18,333	$51.41	$942,499.53
7/21/2021	Vicki L. Sato	Director	Sell	1,666	$65.13	$108,506.58
6/23/2021	Vicki L. Sato	Director	Sell	1,666	$70.74	$117,852.84
6/7/2021	Marc Tessier-Lavigne	Director	Sell	94,378	$70.35	$6,639,492.30
6/4/2021	Alexander O. Schuth	COO	Sell	10,000	$64.55	$645,500.00
6/1/2021	Ryan J. Watts	CEO	Sell	18,333	$61.40	$1,125,646.20
5/26/2021	Vicki L. Sato	Director	Sell	1,666	$65.37	$108,906.42
5/24/2021	Marc Tessier-Lavigne	Director	Sell	8,806	$60.02	$528,536.12
5/21/2021	Marc Tessier-Lavigne	Director	Sell	37,957	$60.13	$2,282,354.41
5/4/2021	Alexander O. Schuth	COO	Sell	10,000	$55.49	$554,900.00
4/28/2021	Vicki L. Sato	Director	Sell	1,666	$62.15	$103,541.90
4/5/2021	Alexander O. Schuth	COO	Sell	10,000	$56.09	$560,900.00
4/1/2021	Marc Tessier-Lavigne	Director	Sell	50,000	$56.62	$2,831,000.00
4/1/2021	Ryan J. Watts	CEO	Sell	18,334	$56.60	$1,037,704.40
3/29/2021	Carole Ho	Insider	Sell	2,822	$54.62	$154,137.64
3/15/2021	Steve E. Krognes	CFO	Sell	50,000	$61.89	$3,094,500.00
3/4/2021	Alexander O. Schuth	COO	Sell	10,000	$61.02	$610,200.00
3/3/2021	Vicki L. Sato	Director	Sell	1,666	$61.61	$102,642.26
2/16/2021	Steve E. Krognes	CFO	Sell	50,000	$65.09	$3,254,500.00
2/12/2021	Douglas K Bratton	Major Shareholder	Sell	2,216,798	$65.00	$144,091,870.00
2/11/2021	Alexander O. Schuth	COO	Sell	3,047	$70.35	$214,356.45
2/11/2021	Carole Ho	Insider	Sell	3,156	$70.33	$221,961.48
2/11/2021	Ryan J. Watts	CEO	Sell	9,473	$70.30	$665,951.90
2/11/2021	Steve E. Krognes	CFO	Sell	3,035	$70.34	$213,481.90
2/9/2021	Alexander O Schuth	COO	Sell	1,468	$74.80	$109,806.40	10,686
2/9/2021	Carole Ho	Insider	Sell	1,470	$74.68	$109,779.60	1,476
2/9/2021	Ryan J Watts	CEO	Sell	5,112	$73.79	$377,214.48
2/9/2021	Steve E Krognes	CFO	Sell	1,448	$74.68	$108,136.64	14,427
2/4/2021	Alexander O Schuth	COO	Sell	10,000	$67.84	$678,400.00	10,686
2/1/2021	Ryan J Watts	CEO	Sell	18,334	$68.44	$1,254,778.96
1/15/2021	Steve E Krognes	CFO	Sell	50,000	$71.45	$3,572,500.00	10,177
1/4/2021	Alexander O Schuth	COO	Sell	70,000	$74.95	$5,246,500.00	10,686
1/4/2021	Ryan J Watts	CEO	Sell	88,334	$74.96	$6,621,516.64
12/21/2020	David P. Schenkein	Director	Sell	25,000	$90.06	$2,251,500.00
12/14/2020	Douglas K Bratton	Major Shareholder	Sell	17,825	$80.38	$1,432,773.50
12/11/2020	Douglas K Bratton	Major Shareholder	Sell	46,799	$80.05	$3,746,259.95
11/12/2020	David P. Schenkein	Director	Sell	30,000	$70.05	$2,101,500.00	25,000
11/4/2020	David P. Schenkein	Director	Sell	10,000	$50.18	$501,800.00	65,000
10/9/2020	Carole Ho	Insider	Sell	30,000	$41.22	$1,236,600.00
9/10/2020	Carole Ho	Insider	Sell	3,689	$31.00	$114,359.00
6/29/2020	Douglas K Bratton	Major Shareholder	Sell	82,578	$24.01	$1,982,697.78
6/26/2020	Douglas K Bratton	Major Shareholder	Sell	122,077	$23.94	$2,922,523.38
6/22/2020	Douglas K Bratton	Major Shareholder	Sell	90,056	$24.78	$2,231,587.68
6/19/2020	Douglas K Bratton	Major Shareholder	Sell	144,920	$24.54	$3,556,336.80
6/16/2020	Marc Tessier-Lavigne	Director	Sell	400,000	$26.10	$10,440,000.00	2,739,043
3/30/2020	Alexander O Schuth	COO	Sell	1,427	$19.49	$27,812.23	28,662
3/30/2020	Ryan J Watts	CEO	Sell	4,807	$19.48	$93,640.36	22,013
3/30/2020	Steve E Krognes	CFO	Sell	1,428	$19.48	$27,817.44	1,006,488

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

67.26% of Denali Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/6/2023	Rockefeller Capital Management L.P.	9,858	$0.27M	0.0%	-16.7%	0.007%
2/28/2023	Voya Investment Management LLC	162,996	$4.53M	0.0%	+2.6%	0.120%
2/22/2023	Teachers Retirement System of The State of Kentucky	206,500	$5.74M	0.1%	+16.5%	0.152%
2/17/2023	Linden Thomas Advisory Services LLC	18,264	$0.51M	0.1%	N/A	0.013%
2/16/2023	Point72 Middle East FZE	3,593	$100K	0.0%	N/A	0.003%
2/15/2023	Public Employees Retirement System of Ohio	6,251	$0.17M	0.0%	N/A	0.005%
2/15/2023	Metropolitan Life Insurance Co NY	6,725	$0.19M	0.0%	+13.1%	0.005%
2/15/2023	MetLife Investment Management LLC	57,027	$1.59M	0.0%	+8.8%	0.042%
2/15/2023	Pier 88 Investment Partners LLC	35,240	$0.98M	0.2%	+191.5%	0.026%
2/15/2023	Jane Street Group LLC	14,969	$0.42M	0.0%	N/A	0.011%
2/15/2023	State of Wisconsin Investment Board	86,566	$2.41M	0.0%	-1.1%	0.064%
2/15/2023	Susquehanna Fundamental Investments LLC	91,249	$2.54M	0.0%	N/A	0.067%
2/15/2023	Sandia Investment Management LP	2,500	$70K	0.0%	N/A	0.002%
2/15/2023	T. Rowe Price Investment Management Inc.	633,358	$17.61M	0.0%	+50.0%	0.466%
2/15/2023	Legal & General Group Plc	95,015	$2.64M	0.0%	+10.5%	0.070%
2/15/2023	Mackenzie Financial Corp	7,959	$0.22M	0.0%	+22.1%	0.006%
2/15/2023	Millennium Management LLC	297,093	$8.26M	0.0%	-40.1%	0.219%
2/15/2023	Morgan Stanley	432,486	$12.03M	0.0%	-36.5%	0.318%
2/15/2023	Man Group plc	142,929	$3.98M	0.0%	+315.2%	0.105%
2/15/2023	Norges Bank	1,024,206	$28.48M	0.0%	N/A	0.754%
2/15/2023	E Fund Management Co. Ltd.	14,861	$0.41M	0.0%	+4.3%	0.011%
2/15/2023	Eagle Asset Management Inc.	329,084	$9.09M	0.1%	+28.8%	0.242%
2/15/2023	Gilder Gagnon Howe & Co. LLC	1,767,142	$49.14M	0.9%	-5.2%	1.301%
2/15/2023	Algert Global LLC	29,426	$0.82M	0.0%	+285.5%	0.022%
2/15/2023	Alps Advisors Inc.	92,029	$2.56M	0.0%	+36.7%	0.068%
2/15/2023	Bamco Inc. NY	264,256	$7.35M	0.0%	-3.9%	0.195%
2/14/2023	Point72 Asset Management L.P.	64,400	$1.79M	0.0%	-89.8%	0.047%
2/14/2023	Price T Rowe Associates Inc. MD	3,648,888	$101.48M	0.0%	+4.9%	2.687%
2/14/2023	Marshall Wace LLP	960,639	$26.72M	0.1%	+42.1%	0.707%
2/14/2023	Two Sigma Investments LP	74,435	$2.07M	0.0%	-71.5%	0.055%
2/13/2023	Platinum Investment Management Ltd.	55,341	$1.54M	0.1%	+8.6%	0.041%
2/13/2023	Charles Schwab Investment Management Inc.	836,673	$23.27M	0.0%	+14.5%	0.616%
2/13/2023	Deutsche Bank AG	110,730	$3.08M	0.0%	+9.8%	0.082%
2/13/2023	Barclays PLC	585,965	$16.30M	0.0%	+80.0%	0.431%
2/13/2023	Renaissance Technologies LLC	249,600	$6.94M	0.0%	-36.4%	0.184%
2/13/2023	The Manufacturers Life Insurance Company	112,059	$3.14M	0.0%	+1.6%	0.083%
2/13/2023	Credit Suisse AG	1,533,383	$42.64M	0.0%	-4.8%	1.129%
2/13/2023	Geode Capital Management LLC	2,049,957	$57.01M	0.0%	+15.4%	1.509%
2/13/2023	JPMorgan Chase & Co.	183,976	$5.12M	0.0%	+69.8%	0.135%
2/13/2023	Artal Group S.A.	800,000	$22.25M	1.2%	+33.3%	0.589%
2/13/2023	Teacher Retirement System of Texas	26,149	$0.73M	0.0%	-7.3%	0.019%
2/10/2023	Bank of America Corp DE	334,772	$9.31M	0.0%	+52.0%	0.247%
2/10/2023	American International Group Inc.	51,484	$1.43M	0.0%	+10.1%	0.038%
2/10/2023	Amalgamated Bank	17,959	$0.50M	0.0%	+12.7%	0.013%
2/10/2023	Sei Investments Co.	12,701	$0.35M	0.0%	-20.7%	0.009%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	61,096	$1.70M	0.0%	-45.7%	0.045%
2/10/2023	Sectoral Asset Management Inc.	243,850	$6.78M	1.3%	+0.2%	0.180%
2/10/2023	Victory Capital Management Inc.	13,256	$0.37M	0.0%	+14.0%	0.010%
2/10/2023	Tekla Capital Management LLC	272,520	$7.58M	0.3%	+22.5%	0.201%
2/10/2023	Advisor Group Holdings Inc.	2,220	$62K	0.0%	-21.6%	0.002%
2/10/2023	Aigen Investment Management LP	10,751	$0.30M	0.0%	N/A	0.008%
2/10/2023	PNC Financial Services Group Inc.	1,669	$46K	0.0%	+85.2%	0.001%
2/10/2023	Mitsubishi UFJ Trust & Banking Corp	301,870	$8.40M	0.0%	-1.8%	0.222%
2/10/2023	Artisan Partners Limited Partnership	435,673	$12.12M	0.0%	-1.7%	0.321%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	54,607	$1.52M	0.0%	+11.7%	0.040%
2/9/2023	Victory Capital Management Inc.	13,136	$0.40M	0.0%	+13.0%	0.010%
2/9/2023	Dimensional Fund Advisors LP	558,258	$15.53M	0.0%	-8.5%	0.411%
2/9/2023	Principal Financial Group Inc.	526,459	$14.64M	0.0%	-3.6%	0.388%
2/9/2023	Citigroup Inc.	128,120	$3.56M	0.0%	-33.5%	0.094%
2/9/2023	HighTower Advisors LLC	22,209	$0.62M	0.0%	+18.0%	0.016%
2/9/2023	Mercer Global Advisors Inc. ADV	27,030	$0.75M	0.0%	+3.1%	0.020%
2/8/2023	Raymond James & Associates	9,917	$0.28M	0.0%	N/A	0.007%
2/8/2023	UBS Group AG	120,181	$3.34M	0.0%	+183.1%	0.088%
2/8/2023	Pier 88 Investment Partners LLC	35,240	$0.98M	0.2%	+191.5%	0.026%
2/8/2023	Skandinaviska Enskilda Banken AB publ	309,092	$8.60M	0.1%	+6.1%	0.228%
2/8/2023	California Public Employees Retirement System	193,561	$5.38M	0.0%	-3.1%	0.143%
2/8/2023	Swiss National Bank	208,500	$5.80M	0.0%	+2.2%	0.154%
2/8/2023	Russell Investments Group Ltd.	99,373	$2.76M	0.0%	-7.0%	0.073%
2/8/2023	Arizona State Retirement System	24,364	$0.68M	0.0%	+4.2%	0.018%
2/7/2023	Handelsbanken Fonder AB	14,100	$0.39M	0.0%	+5.2%	0.010%
2/7/2023	Envestnet Asset Management Inc.	40,917	$1.14M	0.0%	-1.4%	0.030%
2/7/2023	TD Asset Management Inc	99,209	$2.76M	0.0%	+5.4%	0.073%
2/6/2023	Los Angeles Capital Management LLC	20,902	$0.58M	0.0%	-51.1%	0.015%
2/2/2023	SG Americas Securities LLC	4,546	$0.13M	0.0%	-64.6%	0.003%
2/2/2023	ProShare Advisors LLC	26,908	$0.75M	0.0%	+18.1%	0.020%
2/2/2023	Profund Advisors LLC	14,867	$0.41M	0.0%	+14.7%	0.011%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	12,318	$0.34M	0.0%	+7.0%	0.009%
1/31/2023	AIA Group Ltd	22,762	$0.63M	0.0%	-38.5%	0.017%
1/31/2023	Ironwood Investment Management LLC	19,149	$0.53M	0.4%	-3.8%	0.014%
1/31/2023	VELA Investment Management LLC	13,746	$0.38M	0.2%	+55.5%	0.010%
1/30/2023	New York State Common Retirement Fund	150,954	$4.20M	0.0%	+4.2%	0.111%
1/27/2023	Exchange Traded Concepts LLC	2,584	$72K	0.0%	+18.8%	0.002%
1/24/2023	Baillie Gifford & Co.	15,119,474	$420.47M	0.4%	+2.7%	11.062%
1/18/2023	Exchange Traded Concepts LLC	2,584	$72K	0.0%	+18.8%	0.002%
12/8/2022	Bank of New York Mellon Corp	1,895,292	$58.17M	0.0%	+1.5%	1.396%
11/22/2022	Teachers Retirement System of The State of Kentucky	177,196	$5.44M	0.1%	N/A	0.130%
11/21/2022	California State Teachers Retirement System	112,963	$3.47M	0.0%	-1.7%	0.083%
11/16/2022	BNP Paribas Arbitrage SNC	108,569	$3.33M	0.0%	+386.2%	0.080%
11/15/2022	State Street Corp	4,192,228	$128.66M	0.0%	+11.8%	3.087%
11/15/2022	Dana Investment Advisors Inc.	20,397	$0.63M	0.0%	+52.8%	0.015%
11/15/2022	Castleark Management LLC	127,460	$3.91M	0.2%	N/A	0.094%
11/15/2022	Algert Global LLC	7,634	$0.23M	0.0%	N/A	0.006%
11/15/2022	Mercer Global Advisors Inc. ADV	26,209	$0.80M	0.0%	+9.8%	0.019%
11/15/2022	Two Sigma Advisers LP	183,800	$5.64M	0.0%	+14.5%	0.135%
11/15/2022	Two Sigma Investments LP	261,170	$8.02M	0.0%	+306.0%	0.192%
11/15/2022	Temasek Holdings Private Ltd	5,576,041	$171.13M	1.0%	+3.8%	4.106%
11/15/2022	Trexquant Investment LP	25,629	$0.79M	0.0%	N/A	0.019%
11/15/2022	UBS Asset Management Americas Inc.	530,204	$16.27M	0.0%	+8.8%	0.390%
11/15/2022	Vanguard Group Inc.	8,402,031	$257.86M	0.0%	+1.2%	6.186%
11/15/2022	Price T Rowe Associates Inc. MD	3,478,368	$106.75M	0.0%	-24.6%	2.561%

Data available starting January 2016

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Today's Range

Now: $23.26

$23.04

$23.68

50 Day Range

MA: $28.36

$23.22

$32.67

52 Week Range

Now: $23.26

$20.24

$39.43

Volume

713,646 shs

Average Volume

683,871 shs

Market Capitalization

$3.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of Denali Therapeutics?: Denali Therapeutics' top insider investors include:
Ryan J Watts (CEO)
Marc Tessier-Lavigne (Director)
Alexander O Schuth (Insider)
Carole Ho (Insider)
Steve E Krognes (Director)
Alexander O Schuth (COO)
Ryan J Watts (CEO)
Steve E Krognes (CFO)
Vicki L Sato (Director)
Learn More about top insider investors at Denali Therapeutics.
Who are the major institutional investors of Denali Therapeutics?: Denali Therapeutics' top institutional shareholders include:
Baillie Gifford & Co. — 11.06%
Price T Rowe Associates Inc. MD — 2.69%
Geode Capital Management LLC — 1.51%
Gilder Gagnon Howe & Co. LLC — 1.30%
Credit Suisse AG — 1.13%
Norges Bank — 0.75%
Learn More about top institutional investors of Denali Therapeutics stock.
Which major investors are selling Denali Therapeutics stock?: Within the previous quarter, DNLI stock was sold by these institutional investors:
Point72 Asset Management L.P.
Morgan Stanley
Millennium Management LLC
Two Sigma Investments LP
Renaissance Technologies LLC
Gilder Gagnon Howe & Co. LLC
Credit Suisse AG
Citigroup Inc.
During the last year, company insiders that have sold Denali Therapeutics company stock include:
Ryan J Watts (CEO)
Marc Tessier-Lavigne (Director)
Alexander O Schuth (Insider)
Carole Ho (Insider)
Steve E Krognes (Director)
Learn More investors selling Denali Therapeutics stock.
Which major investors are buying Denali Therapeutics stock?: Within the last quarter, DNLI stock was purchased by institutional investors including:
Norges Bank
Baillie Gifford & Co.
Marshall Wace LLP
Geode Capital Management LLC
Barclays PLC
T. Rowe Price Investment Management Inc.
Artal Group S.A.
Price T Rowe Associates Inc. MD

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

DNLI Insider Trading

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

Denali Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Denali Therapeutics?

Who are the major institutional investors of Denali Therapeutics?

Which major investors are selling Denali Therapeutics stock?

Which major investors are buying Denali Therapeutics stock?